Neurocrine Biosciences, Inc. (NBIX) SEC filings
NBIX SEC filings moved a median of -1.20% by the close. NBIX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NBIX overview →
55 measured NBIX SEC filing events.
Where these NBIX SEC filings landedvs 55 measured NBIX SEC filing reactions
| Middle 50% of NBIX SEC filing reactions | -1.98% to +1.03% |
|---|---|
| Median reaction (to close) | -1.20% |
| Measured reactions | 55 |
Point-in-time · zero look-ahead
Half of the 55 NBIX SEC filing events with a measured close landed between -1.98% and +1.03%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K NEUROCRINE BIOSCIENCES For: Sep 25 | SEC filing · Form 8-K | +1.21% | +0.07% | |
| Form 10-Q NEUROCRINE BIOSCIENCES For: Jun 30 | SEC filing · Form 10-Q | -6.66% | -9.52% | |
| Form 8-K/A NEUROCRINE BIOSCIENCES For: May 14 | SEC filing · Form 8-K | -1.67% | -0.76% | |
| Form S-8 NEUROCRINE BIOSCIENCES | SEC filing · Form S-8 | -1.67% | -0.76% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Jul 30 | SEC filing · Form 8-K | -6.66% | -9.52% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: May 27 | SEC filing · Form 8-K | -0.29% | +1.01% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: May 14 | SEC filing · Form 8-K | +0.05% | -0.94% | |
| Form 10-Q NEUROCRINE BIOSCIENCES For: Mar 31 | SEC filing · Form 10-Q | -1.68% | -1.20% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: May 05 | SEC filing · Form 8-K | -1.68% | -1.20% | |
| Form ARS NEUROCRINE BIOSCIENCES For: Dec 31 | SEC filing · Form ARS | +0.17% | -1.98% | |
| Form DEF 14A NEUROCRINE BIOSCIENCES For: Apr 15 | SEC filing · Form DEF | +0.17% | -1.98% | |
| Form DEFA14A NEUROCRINE BIOSCIENCES | SEC filing · Form DEFA14A | +0.17% | -1.98% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Apr 05 | SEC filing · Form 8-K | -1.02% | +1.18% | |
| Form 10-K NEUROCRINE BIOSCIENCES For: Dec 31 | SEC filing · Form 10-K | -2.88% | -6.98% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Feb 11 | SEC filing · Form 8-K | -2.88% | -6.98% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Nov 21 | SEC filing · Form 8-K | +0.56% | +1.31% | |
| Form 10-Q NEUROCRINE BIOSCIENCES For: Sep 30 | SEC filing · Form 10-Q | -0.61% | -1.41% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Oct 28 | SEC filing · Form 8-K | -0.61% | -1.41% | |
| Form 10-Q NEUROCRINE BIOSCIENCES For: Jun 30 | SEC filing · Form 10-Q | -5.43% | -6.47% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Jul 30 | SEC filing · Form 8-K | -5.43% | -6.47% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: May 30 | SEC filing · Form 8-K | +0.45% | +1.04% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: May 21 | SEC filing · Form 8-K | +0.03% | +1.80% | |
| Form S-8 NEUROCRINE BIOSCIENCES | SEC filing · Form S-8 | +0.15% | -0.46% | |
| Form S-8 POS NEUROCRINE BIOSCIENCES | SEC filing · Form S-8 | +0.15% | -0.46% | |
| Form 10-Q NEUROCRINE BIOSCIENCES For: Mar 31 | SEC filing · Form 10-Q | +2.95% | -3.32% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: May 05 | SEC filing · Form 8-K | +2.95% | -3.32% | |
| Form ARS NEUROCRINE BIOSCIENCES For: Dec 31 | SEC filing · Form ARS | +0.69% | -2.63% | |
| Form DEF 14A NEUROCRINE BIOSCIENCES For: Apr 09 | SEC filing · Form DEF | +0.69% | -2.63% | |
| Form DEFA14A NEUROCRINE BIOSCIENCES | SEC filing · Form DEFA14A | +0.69% | -2.63% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Apr 02 | SEC filing · Form 8-K | -0.35% | -3.77% | |
| Form 10-K NEUROCRINE BIOSCIENCES For: Dec 31 | SEC filing · Form 10-K | -0.37% | +0.66% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Feb 06 | SEC filing · Form 8-K | +1.63% | -2.70% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Jan 24 | SEC filing · Form 8-K | -0.23% | +1.15% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Dec 20 | SEC filing · Form 8-K | +0.00% | +0.33% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Oct 31 | SEC filing · Form 8-K | +1.09% | +1.40% | |
| Form 10-Q NEUROCRINE BIOSCIENCES For: Sep 30 | SEC filing · Form 10-Q | +1.94% | -1.68% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Oct 30 | SEC filing · Form 8-K | +1.94% | -1.68% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Oct 11 | SEC filing · Form 8-K | +0.43% | +1.14% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Aug 28 | SEC filing · Form 8-K | -1.59% | -1.78% | |
| Form 10-Q NEUROCRINE BIOSCIENCES For: Jun 30 | SEC filing · Form 10-Q | +2.96% | +1.94% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Aug 01 | SEC filing · Form 8-K | +2.96% | +1.94% | |
| Form S-8 NEUROCRINE BIOSCIENCES | SEC filing · Form S-8 | -0.04% | +0.29% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: May 24 | SEC filing · Form 8-K | -1.16% | -1.28% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: May 22 | SEC filing · Form 8-K | -0.11% | -0.79% | |
| Form 10-Q NEUROCRINE BIOSCIENCES For: Mar 31 | SEC filing · Form 10-Q | -1.67% | +2.03% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: May 01 | SEC filing · Form 8-K | -1.67% | +2.03% | |
| Form ARS NEUROCRINE BIOSCIENCES For: Dec 31 | SEC filing · Form ARS | -0.02% | -1.52% | |
| Form DEF 14A NEUROCRINE BIOSCIENCES For: May 22 | SEC filing · Form DEF | -0.02% | -1.52% | |
| Form DEFA14A NEUROCRINE BIOSCIENCES | SEC filing · Form DEFA14A | -0.02% | -1.52% | |
| Form 10-K NEUROCRINE BIOSCIENCES For: Dec 31 | SEC filing · Form 10-K | +0.54% | -1.38% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Feb 07 | SEC filing · Form 8-K | +2.76% | +0.96% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Nov 10 | SEC filing · Form 8-K | +0.40% | +3.18% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Nov 09 | SEC filing · Form 8-K | -0.34% | +0.82% | |
| Form 10-Q NEUROCRINE BIOSCIENCES For: Sep 30 | SEC filing · Form 10-Q | +2.48% | +4.19% | |
| Form 8-K NEUROCRINE BIOSCIENCES For: Oct 31 | SEC filing · Form 8-K | +2.48% | +4.19% |
Keep exploring
More NBIX: earnings → · analyst actions → · NBIX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Kadmon Holdings, Inc. (KDMN) | 628 | 0.00% | 46% |
| GTX (GTXI) | 623 | 0.00% | 45% |
| Viveve Medical, Inc. (VIVE) | 621 | -0.82% | 38% |
| CHINA BIOLOGIC PRODUCTS (CBPO) | 619 | -0.04% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.